| Database ID | Agent | Target | Cancer Type | Detail |
| DB01081 | ramucirumab | Vascular endothelial growth factor receptor 2 | breast cancer | view |
| DB01082 | sunitinib, trastuzumab | NA | breast cancer | view |
| DB01083 | lapatinib, pazopanib | NA | breast cancer | view |
| DB01084 | lapatinib, trastuzumab | NA | breast cancer | view |
| DB01085 | alisertib | aurora kinase A | advanced solid tumors | view |
| DB01086 | alisertib | aurora kinase A | ovarian, primary peritoneal, or fallopian tube carcinoma | view |
| DB01087 | AT101 | Bcl2, BclxL, Mcl1, and Bclw | prostate cancer | view |
| DB01088 | Ruxolitinib | Tyrosineprotein kinase JAK2 | pancreatic cancer | view |